<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sat, 11 Apr 2026 04:25:23 -0400--><rss version="2.0">
    <channel>
        <title>Avalo Therapeutics, Inc. (AVTX) Presentations</title>
        <link>https://ir.avalotx.com/news-events-presentations/presentations/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_ea697aa916e28469528b0006da59afb9/avalotx/files/theme/images/logo-sm.png</url>
                <title>Avalo Therapeutics, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[March 2026 Corporate Presentation]]></title>
                <description><![CDATA[]]></description>
                <link>https://d1io3yog0oux5.cloudfront.net/_807c1efe4cfc99a442184621b5aa6ba5/avalotx/db/367/3402/pdf/Avalo+Corporate+Presentation_March+2026.pdf</link>
                <pubDate>Mon, 23 Mar 26 00:00:00 -0400</pubDate>
                <guid>https://d1io3yog0oux5.cloudfront.net/_807c1efe4cfc99a442184621b5aa6ba5/avalotx/db/367/3402/pdf/Avalo+Corporate+Presentation_March+2026.pdf</guid>
                                                                            </item>
            </channel>
</rss>